Commitments and Contingent Liabilities - Narrative (Details)							1 Months Ended				3 Months Ended		6 Months Ended	9 Months Ended		12 Months Ended
	Oct. 26, 2022 USD ($)	Jul. 05, 2022 USD ($)	Jun. 27, 2022 USD ($)	May 03, 2022 USD ($)	Apr. 02, 2022 USD ($) state installment distributor	Sep. 28, 2021 USD ($)	Dec. 31, 2022 USD ($) case	Oct. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Mar. 31, 2016 USD ($)	Dec. 31, 2022 USD ($) case	Sep. 30, 2022 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) case site	Dec. 31, 2021 USD ($)	Mar. 31, 2021 USD ($)	Nov. 30, 2022 USD ($)	Dec. 31, 2018 USD ($)	Apr. 30, 2018 USD ($)	Dec. 31, 2017 USD ($)
Loss Contingencies [Line Items]
Opioid stewardship act, new york, annual surcharge																	$ 42,000,000	$ 100,000,000	$ 100,000,000	$ 100,000,000
Proceeds from legal settlements											$ 129,000,000				$ 46,000,000
Operating Segments | U.S. Pharmaceutical
Loss Contingencies [Line Items]
Proceeds from legal settlements								$ 129,000,000
New York Opioid Tax Surcharge | U.S. Pharmaceutical
Loss Contingencies [Line Items]
Charge recorded related to Company's share of the litigation settlement											18,000,000					$ 50,000,000
Loss contingency accrual, payments							$ 11,000,000		$ 26,000,000
Environmental Litigation
Loss Contingencies [Line Items]
Hazardous substance sites | site														14
Estimated environmental assessment and cleanup costs										$ 1,400,000,000
Accrual for environmental loss contingencies							$ 3,000,000				$ 3,000,000			$ 3,000,000
National Prescription Opioid Litigation
Loss Contingencies [Line Items]
Number of other national distributors named in suit | distributor					2
Number of states in which court cases are pending | state					46
Number of eligible states | state					49
Award payable under proposed framework					$ 7,400,000,000
Portion of settlement to be paid by the Company (percent)					38.10%
Portion of settlement award to be used by state and local government for remediation (percent)					85.00%
Loss contingency, number of cases dismissed | case							2,300				2,300			2,300
National Prescription Opioid Litigation | State of West Virginia and Subdivisions
Loss Contingencies [Line Items]
Award payable under proposed framework		$ 152,000,000
National Prescription Opioid Litigation | Cherokee Nation
Loss Contingencies [Line Items]
Award payable under proposed framework						$ 29,000,000
Portion of settlement to be paid by the Company (percent)						38.10%
Loss contingency, settlement, installment payments, term						6 years 6 months
National Prescription Opioid Litigation | Native American Tribes Other Than Cherokee Nation
Loss Contingencies [Line Items]
Award payable under proposed framework	$ 167,000,000
Portion of settlement to be paid by the Company (percent)	38.10%
Loss contingency, settlement, installment payments, term	6 years
Litigation settlement, amount awarded to other party, percentage of total settlement to be used to remediate damages						0.85
Canada | National Prescription Opioid Litigation
Loss Contingencies [Line Items]
Complaints filed against the entity | case							4				4			4
Canada | National Prescription Opioid Litigation | Governmental entities
Loss Contingencies [Line Items]
Complaints filed against the entity | case							3				3			3
Canada | National Prescription Opioid Litigation | An individual
Loss Contingencies [Line Items]
Complaints filed against the entity | case							1				1			1
Three Largest U.S. Pharmaceutical Distributors | National Prescription Opioid Litigation
Loss Contingencies [Line Items]
Award payable under proposed framework					$ 19,500,000,000
Period over which award would be payable under proposed framework					18 years
Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | State of West Virginia and Subdivisions
Loss Contingencies [Line Items]
Award payable under proposed framework		$ 400,000,000
Portion of settlement to be paid by the Company (percent)		38.10%
Loss contingency, settlement, installment payments, term		11 years
Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | Cherokee Nation
Loss Contingencies [Line Items]
Award payable under proposed framework						$ 75,000,000
Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | Native American Tribes Other Than Cherokee Nation
Loss Contingencies [Line Items]
Award payable under proposed framework	$ 440,000,000
Pending | National Prescription Opioid Litigation | State of Alabama and Subdivisions
Loss Contingencies [Line Items]
Award payable under proposed framework					$ 141,000,000
Loss contingency, settlement, number of installment payments | installment					10
Litigation expense					$ 33,000,000
Settled Litigation | National Prescription Opioid Litigation | State of Washington and Subdivisions
Loss Contingencies [Line Items]
Award payable under proposed framework				$ 197,000,000
Portion of settlement to be paid by the Company (percent)				38.10%
Settled Litigation | National Prescription Opioid Litigation | State of Oklahoma and Subdivisions
Loss Contingencies [Line Items]
Award payable under proposed framework			$ 117,000,000
Portion of settlement to be paid by the Company (percent)			38.10%
Settled Litigation | National Prescription Opioid Litigation | Settling Governmental Entities and Cherokee Nation
Loss Contingencies [Line Items]
Settlement payment												$ 106,000,000	$ 1,000,000,000
Settled Litigation | Distributors | National Prescription Opioid Litigation | State of Washington and Subdivisions
Loss Contingencies [Line Items]
Award payable under proposed framework				$ 518,000,000
Period over which award would be payable under proposed framework				18 years
Settled Litigation | Distributors | National Prescription Opioid Litigation | State of Oklahoma and Subdivisions
Loss Contingencies [Line Items]
Award payable under proposed framework			$ 308,000,000
Period over which award would be payable under proposed framework			18 years